Joint Reconstruction Devices and Equipment Global Market Report 2024

The joint reconstruction devices and equipment market size has grown strongly in recent years. It will grow from $21.86 billion in 2023 to $23.62 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The expansion observed in the historical period can be attributed to advancements in technologies, strong economic growth in emerging markets, and an increase in healthcare expenditure.

The joint reconstruction devices and equipment market size is expected to see strong growth in the next few years. It will grow to $31.35 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to factors such as an increase in joint reconstruction disorders, rapid growth in the geriatric population, and an increase in joint replacement surgical procedures. Major trends expected in the forecast period include developing IoT-enabled solutions for joint reconstruction surgery to carry out procedures without human interaction, using artificial intelligence to reduce costs and time, investing in developing robotics products for joint reconstruction surgery, focusing on merger and acquisition activities for business expansion, and investing in 3D printing technology due to its significant improvement over traditional joint reconstruction surgery.

The market is being driven by the substantial number of patients affected by joint reconstruction diseases. Many patients are opting for joint replacement treatments due to their increased safety and reliability compared to other available treatments for joint diseases. The prevalence of joint reconstruction diseases, including osteoarthritis, knee and hip injuries, road accidents, cartilage, and labral injuries, is contributing to the growing patient pool. Osteoarthritis, a common joint disorder, particularly affecting the geriatric population globally, can be effectively treated through joint replacement surgeries utilizing orthopedic knee and hip implants. The Arthritis Foundation predicts that approximately 67 million people will suffer from arthritis by 2030, underscoring the increasing demand for joint reconstruction devices and equipment.

The rising incidence of orthopedic conditions is expected to drive the expansion of the joint reconstruction devices and equipment market. Orthopedic conditions, also known as musculoskeletal conditions, encompass a wide range of medical issues affecting the musculoskeletal system. The growing prevalence of orthopedic conditions is a key factor influencing the joint reconstruction devices and equipment market, offering solutions to various orthopedic issues to alleviate pain, enhance mobility, and restore function to damaged joints. For instance, studies by Taylor and Francis Group indicate that osteoporosis leads to over 8.9 million fractures annually, emphasizing the significance of addressing orthopedic conditions. Additionally, Lancashire County Council reports an estimated 470,000 workers affected by work-related musculoskeletal disorders between 2020 and 2021. Hence, the increasing prevalence of orthopedic conditions is fueling the growth of the joint reconstruction devices and equipment market.

Major companies in the joint reconstruction devices sector are increasingly investing in 3D printing technology, which offers significant advancements over traditional joint reconstruction surgery. This technique enables the reconstruction of bones as a preoperative plan, allowing patients to undergo preoperative MRI or CT scans. This innovation enhances safety and can positively impact treatment adherence. For example, Exactech, a US-based developer of innovative implants and instrumentation, launched a novel total hip arthroplasty system in August 2022. The comprehensive system integrates various innovative design features to assist surgeons in achieving optimal outcomes for their patients.

Joint reconstruction devices and equipment fall under Class III devices in the orthopedic devices market, regulated by bodies such as the US Food and Drug Administration (FDA). Medical device manufacturers must adhere to regulatory requirements, including facility registration and device listing under the Federal Food, Drug, and Cosmetic Act (FFDCA). Manufacturers can obtain premarket approval through clinical studies and a premarket approval (PMA) application or by submitting a 510(k)-notification demonstrating substantial equivalence to a predicate device already on the market.

In January 2021, Stryker Corporation, a US-based medical technologies company, acquired OrthoSensor, a US-based developer of orthopedic devices and digital knee replacement solutions, for an undisclosed amount. This strategic acquisition positions Stryker to advance its growth in smart sensor technologies within the orthopedic sector.

Major companies operating in the joint reconstruction devices and equipment market report are Stryker Corporation, Zimmer Biomet, Johnson & Johnson, Smith & Nephew, Globus Medical, DJO Global Inc., Aesculap Implant Systems LLC, Medtronic, CONMED Corporation, Össur, Allegra Orthopedics, DePuy Synthes, Tornier Inc., Corin Group Plc., Covidien PLC, PolyNovo Limited, Exactech Inc., United Orthopedic Corporation, Victrex, Evonik, Royal DSM, Lepu Medical Technology Company (Beijing) Co. Ltd., Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., Shanghai Runda Medical Technology Co. Ltd., GE Healthcare China Co. Ltd., Smiths Medical (Beijing) Co. Ltd., Nuvasive Inc., AAP Implantate AG, Waldemar Link GmbH & Co. KG, Amplitude SAS, Beznoska Company Ltd., Sanatmetal Ltd., Medin a.s., Collagen Matrix Inc., XpandOrtho, Integra Lifesciences, NEOORTHO, Manoel Amaral Baumer, Biomecânica, ORTOBIO, Ortosintese, IMPOL Próteses Ortopédicas, Wright Medical, B. Braun, Meril Life, Zimmer (Shaarani Group), Corin South Africa (Pty) Ltd., Medtronic Africa, EgiFix Medical.

North America was the largest region in the global joint reconstruction devices and equipment market in 2023. Asia-Pacific was the second largest market in joint reconstruction devices and equipment market. The regions covered in the joint reconstruction devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the joint reconstruction devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary product types of joint reconstruction devices and equipment include knee reconstruction devices, hip reconstruction devices, and extremity reconstruction devices. Hip reconstruction devices are specifically designed to restore mobility and alleviate pain associated with conditions such as arthritis and other hip-related diseases or injuries. Various applications of joint reconstruction devices include arthrodesis, arthroscopy, joint replacement surgery, osteotomy, resurfacing surgery, and small joint surgery. End-users of these devices typically include hospitals, orthopedic clinics, and ambulatory surgical centers.

The joint reconstruction devices and equipment market research report is one of a series of new reports that provides joint reconstruction devices and equipment market statistics, including joint reconstruction devices and equipment industry global market size, regional shares, competitors with a joint reconstruction devices and equipment market share, detailed joint reconstruction devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the joint reconstruction devices and equipment industry. This joint reconstruction devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint reconstruction devices and equipment market consist of sales of knee reconstruction devices, hip reconstruction devices, and extremity reconstruction devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.